ENLIVEX THERAPEUTICS LTD (ENLV) Stock Balance Sheet
NASDAQ:ENLV - Nasdaq - IL0011319527 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.29M | N/A | N/A | 2.12M | 1.20M | |||
| Cash Equivalents | 759.00K | 1.04M | 0.00 | 47.82M | 10.00M | |||
| Marketable Securities | 18.50M | 20.20M | 26.51M | 300.00K | 72.93M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 2.10M | 2.50M | 6.44M | 2.09M | 2.31M | |||
| Total Current Assets | 22.65M | 25.99M | 33.76M | 52.33M | 86.44M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.07M | 1.15M | 2.58M | 14.90M | 8.22M | |||
| Other Non-Current Assets | 319.00K | 541.00K | 487.00K | 410.00K | 490.00K | |||
| Total Non-Current Assets | 1.39M | 1.69M | 3.07M | 15.31M | 8.71M | |||
| TOTAL ASSETS | 24.04M | 27.69M | 36.83M | 67.64M | 95.15M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | N/A | |||
| Accrued Expenses | 2.61M | 2.85M | 4.00M | 4.66M | 3.73M | |||
| Accounts Payable | 533.00K | 811.00K | 827.00K | 1.95M | 880.00K | |||
| Other Current Liabilities | 0.00 | 142.00K | 1.23M | N/A | 110.00K | |||
| Total Current Liabilities | 3.14M | 3.80M | 6.06M | 6.61M | 4.72M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 264.00K | 299.00K | 686.00K | 4.19M | 5.39M | |||
| Total Non-Current Liabilities | 264.00K | 299.00K | 686.00K | 4.19M | 5.39M | |||
| TOTAL LIABILITIES | 3.41M | 4.10M | 6.75M | 10.80M | 10.11M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -130.56M | -127.11M | -112.09M | -83.03M | -51.97M | |||
| Additional Paid In Capital | 147.38M | 146.91M | 138.94M | 136.65M | 133.80M | |||
| Common Shares | 2.71M | 2.69M | 2.14M | 2.12M | 2.11M | |||
| Other Shareholders' Equity | 1.10M | 1.10M | 1.10M | 1.10M | 1.10M | |||
| Shares Outstanding | 23.85M | 23.65M | 18.60M | 18.42M | 18.33M | |||
| Tangible Book Value per Share | 0.86 | 1.00 | 1.62 | 3.09 | 4.64 | |||
| Total Shareholders' Equity | 20.63M | 23.59M | 30.08M | 56.84M | 85.04M | |||
| TOTAL LIABILITIES AND EQUITY | 24.04M | 27.69M | 36.83M | 67.64M | 95.15M | |||
| Statistics | ||||||||
| Current Ratio | 7.20 | 6.84 | 5.57 | 7.92 | 18.31 | |||
| Return On Assets (ROA) | -59.60% | -54.23% | -78.92% | -45.92% | -15.21% | |||
| Return On Equity (ROE) | -69.45% | -63.65% | -96.62% | -54.64% | -17.02% | |||
All data in USD , ROIC based on taxRate of 0.21